Journal of Clinical Psychiatry Issue 77(12)

Low Hemoglobin Levels and Risk of Developing Depression in the Elderly: Results From the Prospective PRO.V.A. Study

Threshold of Dopamine D<sub>2/3</sub> Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia

Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer’s Disease

Time Trends in Lifetime Incidence Rates of First-Time Diagnosed Bipolar and Depressive Disorders Across 16 Years in Danish Psychiatric Hospitals: A Nationwide Study

Glutamatergic Agents as Add-On Medication for the Treatment of Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis

Reducing Dropout in Treatment for Depression: Translating Dropout Predictors Into Individualized Treatment Recommendations

A Randomized Trial of Dialectical Behavior Therapy in High-Risk Suicidal Veterans

Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison

Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study

Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease

Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin

A Radical Proposal to Address the Problem of the Lack of Generalizability of Placebo-Controlled Studies of Antidepressants

Clinical Correlates of Oral Glucose Tolerance Test Performance in Olanzapine-Treated Patients with Schizophrenia or Schizoaffective Disorder

Considering the Complexity of Treatment Response in Psychiatric Clinical Trials

Antibiotics or Infection Itself? The Possible Importance of Inflammatory Cytokines on Mental States

Dr Lurie and Colleagues Reply


Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance

Depression Is Associated With High Levels of C-Reactive Protein and Low Levels of Fractional Exhaled Nitric Oxide: Results From the 2007–2012 National Health and Nutrition Examination Surveys

Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study

Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response

Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study


Psychotherapy for Depression in Older Veterans Via Telemedicine: Effect on Quality of Life, Satisfaction, Treatment Credibility, and Service Delivery Perception

Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database

The Need to Assess Suicidal Risk in the Checklist for Prescribing Opioids